C
C.-P. Hu
Publications - 1
Citations - 106
C.-P. Hu is an academic researcher. The author has contributed to research in topics: Lung cancer & Erlotinib. The author has an hindex of 1, co-authored 1 publications receiving 100 citations.
Papers
More filters
Journal ArticleDOI
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
Gongyan Chen,Ji Feng Feng,Caicun Zhou,Yi-Long Wu,Xiaoqing Liu,Changli Wang,Shucai Zhang,Jian Wang,Songwen Zhou,Shengxiang Ren,Shaoyong Lu,Lei Zhang,C.-P. Hu,Chengping Hu,Y. Luo,Lei Chen,Ming Ye,Jian'An Huang,Xiuyi Zhi,Yuling Zhang,Qingyu Xiu,Jun Ma,Changxuan You +22 more
TL;DR: Erlotinib improves QoL compared with standard chemotherapy in the first-line treatment of patients with EGFR mutation-positive advanced NSCLC and updated PFS analyses from this study are described.